The feasibility, acceptability and preliminary outcomes of a financial navigation program among breast cancer in China: a pilot randomized controlled trial
<h2>Abstract</h2><h3>Background</h3> Financial toxicity (FT) is a global challenge for breast cancer patients due to high costs of care. Financial navigation is a promising intervention to alleviate FT, but evidence remains limited, especially within the Chinese healthcare system. To assess the feasibility, acceptability, and preliminary effects of a financial navigation program among breast cancer patients in China. <h3>Methods</h3> In this single-center, single-blinded pilot randomized controlled trial, a financial navigation program comprising needs assessment, cost-related health education, resource/service referral, and personalized counseling was evaluated. Feasibility was assessed through recruitment, attrition, and adherence rates. Acceptability was measured via participant satisfaction surveys and semi-structured interviews. Preliminary effects were evaluated through cost-related health literacy and three domains of FT. <h3>Results</h3> Twenty-six breast cancer patients were recruited, with a consent rate of 55.9% and a 1-month attrition rate of 7.7%. All participants in the intervention group completed needs assessment and cost-related health education, with resource / service referral and personalized counseling provided as needed. The intervention significantly improved cost-related health literacy, although no statistically significant between-group difference in FT was observed. Most participants reported satisfaction and perceived the program as useful. <h3>Conclusions</h3> The financial navigation program was feasible, acceptable, and effective in improving cost-related health literacy among breast cancer patients in China. <h3>Implications for Practice</h3> This study generated insights to guide future implementation of full-scale RCTs with larger samples and longer durations to further explore the intervention's effectiveness.
Authors
- Jiajia Qiu (ORCID: https://orcid.org/0000-0003-4212-3159)
- Yanling Sun
- Yi Kuang (ORCID: https://orcid.org/0000-0002-2403-7700)
- Weijie Xing (ORCID: https://orcid.org/0000-0002-1327-1059)
- L. Chen
- Xiaoyi Yuan (ORCID: https://orcid.org/0009-0002-4496-7312)
- Lichen Tang
- Junyi Ruan (ORCID: https://orcid.org/0009-0002-5542-3820)
Institutions
- Fudan University (CN)
- Fudan University Shanghai Cancer Center (CN)
Publication Details
- Journal
- The Lancet Regional Health - Western Pacific
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1016/j.lanwpc.2024.101369
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00